Tentative Approval — This application has been tentatively approved by the FDA but is not yet listed in the Orange Book. It is blocked from final approval by unexpired patents or exclusivities on the reference listed drug.
DOLUTEGRAVIR SODIUM
ANDATentative Approval
DOLUTEGRAVIR SODIUM | A209658 | CIPLA LTD
Products (1)
#001 — 50MG
▴
TABLET;ORAL | TA Date: 2018-03-05 00:00:00
No patent or exclusivity listings for this strength.